The University of Oxford is expected to release data on the efficacy of its coronavirus vaccine candidate in the coming weeks, with the latest trial results suggesting it produces a strong immune response in older adults. The ChAdOx1 nCov-2019 vaccine has been shown to trigger a robust immune response in healthy adults aged 56-69 and over 70.
Trending:
Oxford COVID vaccine could build immunity in older people – study